The CTSI scientific community has come together once again to work in partnership in multidisciplinary research teams to discover clues that will lead to better treatments and cures for today’s medical threats. CTSI seeks to cultivate inter-institutional and interdisciplinary collaboration between clinical and basic biomedical...
Before the popularity of yogurts, probiotic drinks or supplements, Dr. John Baker and his team observed a connection between the good bacteria living in your intestines and improved heart health. Dr. Baker and his team confirmed their observations in animal models over the past year. Now,...
Where will the next generation of drugs come from? A major new initiative is helping industry and academic institutions "break down the barriers" to new drug development. The CTSI Regional Drug Discovery and Repurposing Initiative (DDRI) aims to expedite the development of new drugs and...
This month, we invited our partner organizations to answer two questions: "What is CTSI doing right?" and "What can CTSI do better?" As part of the Institute’s robust regional strategic planning process, CTSI Director, Dr. Reza Shaker, is soliciting new, innovative ideas from all institutional members...
A challenge for most clinical research institutions is accruing enough patients to make study results meaningful, particularly in cases involving rare diseases. The same holds true for the Clinical and Translational Science Institute of Southeast Wisconsin (CTSI) and its partner organizations. Now, that is changing. ...
All month long, MCW Libraries is featuring CTS: Clinical and Translational Science. This journal, sponsored by the Clinical and Translational Science Institute of Southeast WI (CTSI), focuses on the work of translational sciences and research, the goal of which is to expedite the time between...
Joshua Field, MD, MS is featured in an article published in the Milwaukee Journal Sentinel titled “New drug could ease pain of sickle cell disease”. The article focuses on Latoyia Webb, one of almost 100 participants in eight cities and one of 20 to 25...
The National Center for Advancing Translational Sciences (NCATS) is announcing an open opportunity to submit proposals to collaborate with the Therapeutics for Rare and Neglected Diseases (TRND) program. The TRND program performs preclinical and early clinical development of new drugs for rare and neglected tropical diseases,...
Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States. A defective gene and its protein product cause the body to produce unusually thick, sticky mucus that clogs the lungs...
Reza Shaker, MD, Joseph E. Geenen Professor and Chief, Division of Gastroenterology and Hepatology, Senior Associate Dean for Clinical and Translational Research at MCW and CTSI Director has developed a device that is designed to minimize or eliminate symptoms of extraesophageal acid reflux disease (EERD)...
Located on the fourth floor of Children’s Hospital of Wisconsin, the Pediatric Translational Research Unit (P-TRU) is a resource for all clinical investigators to perform the translational aspects of their behavioral, clinical and/or observation studies. The P-TRU services all ages from birth through geriatrics. Most...
On Tuesday, January 24th Michele Russell-Einhorn, JD, Senior Director, Office of Human Studies at the Dana-Farber Institute will join us at MCW to present "Managing Research Involving Human Subjects: What, Me Worry?" Ms. Russell-Einhorn will acquaint the audience with the greatest ethical and regulatory priorities...
The Clinical and Translational Science Institute of Southeast Wisconsin is comprised of eight partnering institutions: the Medical College of Wisconsin, the BloodCenter of Wisconsin (BCW), Children’s Hospital of Wisconsin (CHW), Froedtert Hospital (FH), Marquette University (MU), Milwaukee School of Engineering (MSOE), University of Wisconsin-Milwaukee (UWM),...
